HCL Technologies Ltd
NSE:HCLTECH
HCL Technologies Ltd
NSE:HCLTECH
Price:
1 903
INR
-0.44%
Market Closed
Market Cap:
5.2T
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
HCLTECH Alert
HCL Technologies Ltd
1903
-8.35 (-0.44%)
| 52 Week Range |
1 303.55
1 968.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
HCL Technologies Ltd
Balance Sheet
Balance Sheet Decomposition
HCL Technologies Ltd
HCL Technologies Ltd
| Current Assets | 593.3B |
| Cash & Short-Term Investments | 186.7B |
| Receivables | 287.8B |
| Other Current Assets | 118.8B |
| Non-Current Assets | 404.5B |
| Long-Term Investments | 3.5B |
| PP&E | 79.1B |
| Intangibles | 272.6B |
| Other Non-Current Assets | 49.3B |
| Current Liabilities | 227.3B |
| Accounts Payable | 29.2B |
| Accrued Liabilities | 82.4B |
| Short-Term Debt | 150m |
| Other Current Liabilities | 115.5B |
| Non-Current Liabilities | 87.9B |
| Long-Term Debt | 45.6B |
| Other Non-Current Liabilities | 42.3B |
Balance Sheet
HCL Technologies Ltd
HCL Technologies Ltd
Currency: INR
| Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
93 312
|
90 395
|
40 130
|
59 290
|
48 430
|
65 150
|
105 020
|
90 570
|
94 410
|
|
| Cash |
6 121
|
12 053
|
14 910
|
39 820
|
40 040
|
36 060
|
77 820
|
52 670
|
85 060
|
|
| Cash Equivalents |
87 191
|
78 342
|
25 220
|
19 470
|
8 390
|
29 090
|
27 200
|
37 900
|
9 350
|
|
| Short-Term Investments |
7 696
|
14 104
|
26 980
|
47 070
|
78 230
|
102 410
|
91 510
|
110 440
|
177 370
|
|
| Total Receivables |
133 956
|
139 874
|
163 050
|
171 430
|
237 500
|
239 240
|
254 690
|
302 480
|
287 770
|
|
| Accounts Receivables |
107 166
|
108 024
|
122 570
|
150 300
|
182 950
|
178 560
|
211 540
|
264 160
|
267 970
|
|
| Other Receivables |
26 790
|
31 850
|
40 480
|
21 130
|
54 550
|
60 680
|
43 150
|
38 320
|
19 800
|
|
| Inventory |
3 191
|
3 644
|
2 560
|
1 770
|
2 220
|
1 890
|
2 740
|
3 320
|
2 870
|
|
| Other Current Assets |
11 672
|
16 690
|
12 870
|
17 670
|
17 820
|
21 830
|
26 450
|
28 960
|
30 890
|
|
| Total Current Assets |
249 827
|
264 708
|
245 590
|
297 230
|
384 200
|
430 520
|
480 410
|
535 770
|
593 310
|
|
| PP&E Net |
42 063
|
44 462
|
48 800
|
55 280
|
85 420
|
83 640
|
80 460
|
77 480
|
79 090
|
|
| PP&E Gross |
42 063
|
44 462
|
48 800
|
55 280
|
85 420
|
83 640
|
80 460
|
77 480
|
79 090
|
|
| Accumulated Depreciation |
33 473
|
37 668
|
42 140
|
50 330
|
57 410
|
63 780
|
71 840
|
84 100
|
95 580
|
|
| Intangible Assets |
3 454
|
47 333
|
73 940
|
85 340
|
131 940
|
119 010
|
97 430
|
83 440
|
71 300
|
|
| Goodwill |
57 753
|
65 044
|
67 990
|
90 610
|
161 540
|
171 920
|
174 170
|
185 670
|
201 320
|
|
| Note Receivable |
8 564
|
6 713
|
11 770
|
15 210
|
25 000
|
25 680
|
22 750
|
13 750
|
16 520
|
|
| Long-Term Investments |
1 621
|
1 625
|
3 030
|
850
|
780
|
900
|
1 130
|
4 880
|
3 490
|
|
| Other Long-Term Assets |
30 124
|
27 810
|
29 110
|
41 230
|
40 180
|
30 270
|
33 980
|
33 120
|
32 740
|
|
| Other Assets |
57 753
|
65 044
|
67 990
|
90 610
|
161 540
|
171 920
|
174 170
|
185 670
|
201 320
|
|
| Total Assets |
393 406
N/A
|
457 694
+16%
|
480 230
+5%
|
585 750
+22%
|
829 060
+42%
|
861 940
+4%
|
890 330
+3%
|
934 110
+5%
|
997 770
+7%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
23 505
|
37 077
|
26 040
|
24 360
|
21 390
|
23 800
|
29 200
|
29 730
|
29 170
|
|
| Accrued Liabilities |
12 700
|
15 189
|
15 760
|
21 990
|
25 180
|
33 060
|
78 140
|
81 720
|
82 410
|
|
| Short-Term Debt |
2 144
|
621
|
420
|
7 240
|
18 450
|
0
|
0
|
0
|
150
|
|
| Current Portion of Long-Term Debt |
1 385
|
1 440
|
1 770
|
4 940
|
11 140
|
7 700
|
7 610
|
10 110
|
11 790
|
|
| Other Current Liabilities |
58 550
|
59 091
|
57 080
|
64 460
|
161 140
|
109 270
|
72 800
|
92 750
|
103 740
|
|
| Total Current Liabilities |
98 285
|
113 417
|
101 070
|
122 990
|
237 300
|
173 830
|
187 750
|
214 310
|
227 260
|
|
| Long-Term Debt |
7 374
|
3 826
|
3 380
|
29 770
|
50 270
|
57 310
|
55 820
|
37 750
|
45 620
|
|
| Deferred Income Tax |
0
|
0
|
340
|
2 260
|
870
|
1 470
|
1 120
|
1 610
|
7 710
|
|
| Minority Interest |
2 107
|
1 725
|
0
|
4 500
|
5 440
|
6 200
|
920
|
70
|
80
|
|
| Other Liabilities |
11 733
|
9 228
|
11 580
|
12 570
|
22 510
|
24 000
|
25 580
|
26 460
|
34 470
|
|
| Total Liabilities |
119 498
N/A
|
128 196
+7%
|
116 370
-9%
|
172 090
+48%
|
316 390
+84%
|
262 810
-17%
|
271 190
+3%
|
280 060
+3%
|
315 140
+13%
|
|
| Equity | ||||||||||
| Common Stock |
2 821
|
2 854
|
2 780
|
2 710
|
5 430
|
5 430
|
5 430
|
5 430
|
5 430
|
|
| Retained Earnings |
236 337
|
281 661
|
346 150
|
394 230
|
485 120
|
564 180
|
585 080
|
608 470
|
625 880
|
|
| Additional Paid In Capital |
19 630
|
32 443
|
50
|
20
|
70
|
70
|
70
|
70
|
70
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
8 040
|
8 010
|
7 220
|
|
| Other Equity |
15 120
|
12 540
|
14 880
|
16 700
|
22 050
|
29 450
|
36 600
|
48 090
|
58 470
|
|
| Total Equity |
273 908
N/A
|
329 499
+20%
|
363 860
+10%
|
413 660
+14%
|
512 670
+24%
|
599 130
+17%
|
619 140
+3%
|
654 050
+6%
|
682 630
+4%
|
|
| Total Liabilities & Equity |
393 406
N/A
|
457 694
+16%
|
480 230
+5%
|
585 750
+22%
|
829 060
+42%
|
861 940
+4%
|
890 330
+3%
|
934 110
+5%
|
997 770
+7%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
2 821
|
2 854
|
2 784
|
2 713
|
2 714
|
2 714
|
2 714
|
2 714
|
2 714
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
